HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Boesenbergia pandurata attenuates diet-induced obesity by activating AMP-activated protein kinase and regulating lipid metabolism.

Abstract
Obesity, a chronic metabolic disorder, is characterized by enlarged fat mass and dysregulation of lipid metabolism. The medicinal plant, Boesenbergia pandurata (Roxb.) Schltr., has been reported to possess anti-oxidative and anti-inflammatory properties; however, its anti-obesity activity is unexplored. The present study was conducted to determine whether B. pandurata extract (BPE), prepared from its rhizome parts, attenuated high-fat diet (HFD)-induced obesity in C57BL/6J mice. The molecular mechanism was investigated in 3T3-L1 adipocytes and HepG2 human hepatoma cells. BPE treatment decreased triglyceride accumulation in both 3T3-L1 adipocytes and HepG2 hepatocytes by activating AMP-activated protein kinase (AMPK) signaling and regulating the expression of lipid metabolism-related proteins. In the animal model, oral administration of BPE (200 mg/kg/day for 8 weeks) significantly reduced HFD-induced body weight gain without altering the amount of food intake. In addition, elevated serum levels of total cholesterol, low-density lipoprotein cholesterol, and triglycerides were suppressed by BPE administration. Fat pad masses were reduced in BPE-treated mice, as evidenced by reduced adipocyte size. Furthermore, BPE protected against the development of nonalcoholic fatty liver by decreasing hepatic triglyceride accumulation. BPE also activated AMPK signaling and altered the expression of lipid metabolism-related proteins in white adipose tissue and liver. Taken together, these findings indicate that BPE attenuates HFD-induced obesity by activating AMPK and regulating lipid metabolism, suggesting a potent anti-obesity agent.
AuthorsDae-Young Kim, Myung-Suk Kim, Bo-Kyung Sa, Mi-Bo Kim, Jae-Kwan Hwang
JournalInternational journal of molecular sciences (Int J Mol Sci) Vol. 13 Issue 1 Pg. 994-1005 ( 2012) ISSN: 1422-0067 [Electronic] Switzerland
PMID22312299 (Publication Type: Journal Article, Research Support, Non-U.S. Gov't)
Chemical References
  • Anti-Obesity Agents
  • Lipoproteins, LDL
  • Plant Extracts
  • Triglycerides
  • Cholesterol
  • AMP-Activated Protein Kinases
Topics
  • 3T3-L1 Cells
  • AMP-Activated Protein Kinases (metabolism)
  • Animals
  • Anti-Obesity Agents (chemistry, pharmacology)
  • Cholesterol (blood)
  • Diet, High-Fat
  • Eating (drug effects)
  • Hep G2 Cells
  • Humans
  • Lipid Metabolism (drug effects)
  • Lipoproteins, LDL (blood)
  • Liver (metabolism)
  • Male
  • Mice
  • Mice, Inbred C57BL
  • Obesity (etiology, metabolism)
  • Plant Extracts (chemistry, pharmacology)
  • Rhizome (chemistry, metabolism)
  • Triglycerides (blood, metabolism)
  • Weight Gain (drug effects)
  • Zingiberaceae (chemistry, metabolism)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: